跳至主要内容
临床试验/NCT02373878
NCT02373878已完成不适用

Telecoaching Plus a Portion Control Device for Weight Care Management

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2011年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
90
试验地点
1
主要终点
Change in Body Mass Index

研究概览

简要总结

The purpose of this study was to evaluate the impact of telecoaching conducted by a counselor trained in motivational interviewing paired with a portion control device for obese patients receiving care in a certified patient-centered medical home. The investigators will conduct a randomized, controlled clinical trial evaluating the effectiveness of a telecoaching intervention with a portion control device.

详细描述

The intervention will be provided during a 3-month period with follow-up through 6 months after randomization. Body mass index (BMI) and waist circumference measurements will be collected at baseline and at 6, 12, 18, and 24 weeks. Participants will also complete measures assessing eating behaviors and physical activity at baseline and at 12 and 24 weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Men or women ≥ 18 years and ≤ 55 years of age
  • •A BMI of ≥ 30 and ≤ 44.9 kg/m2
  • •Motivated to lose weight
  • •Able to participate fully in all aspects of the study;
  • •Have been provided with, understand, and have signed the informed consent.

排除标准

  • •Unstable angina, myocardial infarction, or coronary angioplasty within the past 3 months or an untreated cardiac dysrhythmia
  • •A history of a gastric bypass procedure or planned gastric bypass
  • •Baseline systolic blood pressure > 180 or diastolic > 100
  • •Another member of their household already participating in this study
  • •Current treatment with another investigational drug for obesity (within 30 days of study entry)
  • •Are pregnant or lactating
  • •History of anorexia or bulimia
  • •Current binge eating disorder as assessed by the Patient Health Questionnaire eating disorder module (PHQ-ED)
  • •Schizophrenia or bipolar disorder or have a PHQ-2 ≥ 337
  • •Have been diagnosed with cancer within the past 5 years
  • •Are currently participating in a program specifically to lose weight or are on a weight loss medication (last 30 days)

研究组 & 干预措施

Telecoaching plus plate

Active Comparator

Telecoaching plus portion control plate

干预措施: Telecoaching plus Plate (Behavioral)

Usual Care

Active Comparator

Usual Care

干预措施: Usual Care (Behavioral)

结局指标

主要结局

Change in Body Mass Index

时间窗: Baseline, 3 months and 6 months

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jon Ebbert

Professor of Medicine

Mayo Clinic

研究点 (1)

Loading locations...

相似试验